Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. SOL S.p.A.
  6. News
  7. Summary
    SOL   IT0001206769

SOL S.P.A.

(SOL)
  Report
Delayed Borsa Italiana  -  11:35:48 2023-02-07 am EST
20.85 EUR   +0.24%
01/23SOL gets B rating on debut in Carbon Disclosure Project
AN
01/16Milan up; high volumes on Bastogi and Esautomotion
AN
01/13Mib tips 26,000; Amplifon rears its head again
AN
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SOL Group: New strategic partnership with ITOP OFFICINE ORTOPEDICHE, as part of its activity in Home Care, in which it operates through VIVISOL.

09/14/2022 | 03:20am EST

per

PRESS RELEASE

SOL Group: New strategic partnership with ITOP OFFICINE ORTOPEDICHE, as part of its activity in Home Care, in which it operates through VIVISOL.

Acquisition of a 51% stake in ITOP S.p.A., a leading company in Italy in the design and production of custom-made aids, prosthesis and orthosis, founded and developed thanks to the fifty-year experience of Francesco Mattogno, the true "soul" of the Company.

The SOL Group consolidates its specialist skills and extends them into innovative sectors to make cutting-edge technological services available to patients.

The SOL Group - multinational operating not only in the technical, industrial and medical gases sector, but also in the home care sector through companies bearing the "VIVISOL" brand - announces that it has acquired through Airsol s.r.l., a company wholly owned by SOL S.p.A., 51% of ITOP S.p.A. Officine Ortopediche, a company that has been operating for 45 years in the design, production, research and innovation of ortho-prosthetic devices for serious orthopedic and neuromuscular pathologies.

This new operation further strengthens the SOL Group's presence in the orthopaedic technology sector, following the investment made last May by the subsidiary Il Point s.r.l. doubling the exhibition space of its point of sale and the construction of a new orthopaedic workshop in Verona.

Founded and developed thanks to the fifty years of experience of Francesco Mattogno, ITOP is the Italian leader in the sector and boasts a team of 165 professionals, including engineers, orthopaedic technicians, occupational therapists and specialized operators. Based in Palestrina (Rome), in the financial year of 2021 the ITOP Group recorded a consolidated turnover of over 20 million euros.

The acquisition was finalized at market prices in line with similar transactions.

Aldo Fumagalli Romario President and CEO of the SOL Group commented: "The SOL Group continues its diversification strategy in sectorssynergistic to thosesectorsin which it already operates, those with high specialization and technological content, to expand the range of products and services to their patients in the healthcare sector. We are happy to start a new development adventure thanks to the partnership with Francesco Mattogno, a successful entrepreneur, and his team of engineers and orthopaedic technicians, with the aim of consolidating and renewing the offer of products and services in the Italian market of orthopaedics'".

Francesco Mattogno, President and CEO of ITOP S.p.A. Officine Ortopediche, declare: "After 52 years of experience in the ortho-prostheticsector, 44 years from the foundation of my company and the great results obtained in the field of Research and Technological Innovation, I have decided to give continuity to what has already been achieved in recent years by entrusting myself to a reality already rooted in the healthcare sector with the perspective of continuous growth and an increasingly entrepreneurial development "

*************************************

SOL Group

SOL is an Italian multinational group listed on the Milan Stock Exchange, which operates in Europe, Turkey, Morocco, India, Brazil and China in two distinct prevailing sectors: the production, applied research and marketing of technical, pure and medicinal gases (Technical Gases Area) and healthcare at home (Home Care Area), as well as in biotechnologies and in the production of energy from renewable sources.

Contacts: Barabino & Partners Marina Riva

Tel 02 72 02 35 35 m.riva@barabino.it

Monza (MB) - Palestrina (RM), 12th of September 2022

Disclaimer

SOL S.p.A. published this content on 14 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 September 2022 07:19:24 UTC.


ę Publicnow 2022
All news about SOL S.P.A.
01/23SOL gets B rating on debut in Carbon Disclosure Project
AN
01/16Milan up; high volumes on Bastogi and Esautomotion
AN
01/13Mib tips 26,000; Amplifon rears its head again
AN
01/11Futures up; Fed members words dampen fears
AN
01/10European bourses down; Powell less hawkish than expected
AN
01/10Stock exchanges retrace; in Milan, oils do well
AN
2022Sol S P A : Group strengthens its international presence in India in the technical gases a..
PU
2022Sol S P A : Nine months 2022 sales
PU
2022Sol Group : Update on the investigation towards Vivisol S.r.l. and two of its managers.
PU
2022Sol Group : investigation towards VIVISOL SRL and its managers
PU
More news
Financials
Sales 2022 1 343 M 1 436 M 1 436 M
Net income 2022 122 M 130 M 130 M
Net Debt 2022 356 M 381 M 381 M
P/E ratio 2022 15,4x
Yield 2022 1,92%
Capitalization 1 891 M 2 023 M 2 023 M
EV / Sales 2022 1,67x
EV / Sales 2023 1,57x
Nbr of Employees 5 235
Free-Float 37,0%
Chart SOL S.P.A.
Duration : Period :
SOL S.p.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOL S.P.A.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 20,85 €
Average target price 24,40 €
Spread / Average Target 17,0%
EPS Revisions
Managers and Directors
Aldo Fumagalli Romario Chairman & Co-Managing Director
Marco Annoni Vice Chairman & Managing Director
Marco Filippi Investor Relations Contact
Anna Gervasoni Independent Director
Antonella Mansi Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SOL S.P.A.17.80%2 023
LINDE PLC-1.02%159 028
AIR PRODUCTS & CHEMICALS, INC.-7.52%62 829
NIPPON SANSO HOLDINGS CORPORATION17.38%7 336
HANGZHOU OXYGEN PLANT GROUP CO.,LTD.-4.40%5 461
LINDE INDIA LIMITED-1.59%3 466